$ 113 billion costs for cancer treatment and respective medication
source: Morning Consult
$ 113 billion costs for cancer treatment and respective medication
source: Morning Consult
We have studied the relationship between core body temperature and human biorhythms in real-life conditions in a study led by Prof. Dr. Werner Korf in collaboration with chronobiologists at the Goethe University of Frankfurt (Ekhart 2017).
The study has demonstrated wide differences in biorhythms from one person to the next, and that individuals show temperature curves that vary from one day to the next.
These new findings demonstrate the importance of individual diagnoses in more targeted drug administration, amongst other things. This would allow an exact determination of the time for certain drugs to be taken. Many drugs show substantial differences in mode of action and compatibility depending on the temperature phase in which they are taken (Lévi 1996). This points to the suitability of core body temperature as a biomarker in chrono-oncology towards improving the efficiency of tumor treatment.
Body-core temperature also shows great potential as a chronobiologic biomarker in diagnosing diseases associated with body-clock dysfunction, such as Alzheimer’s and Parkinson’s.
D Ekhart, H Wicht, T Kersken, H Ackermann, M Kaczmarczyk, G Pretzsch, H Alexander & HW Korf (2017):
Dynamics of core body temperature cycles in longterm measurements under real life conditions in women, Chronobiology International, DOI:10.1080/07420528.2017.1375942